Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice
- PMID: 8977220
Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice
Abstract
To study the involvement of TNF in cerebral pathology in vivo and to define cellular interactions within the central nervous system (CNS) that promote TNF signaling, we have expressed this cytokine either as a wild-type or a mutant transmembrane form in astrocytes or neurons of transgenic mice. Mice expressing wild-type human TNF in either of these cell types spontaneously develop a neurologic disorder manifested by ataxia, seizures, and paralysis and bear histologic evidence of chronic CNS inflammation and degeneration. Moreover, astrocyte-specific expression of transmembrane TNF triggers a similar neurologic phenotype. Interestingly, transgenic mice producing a high level of transmembrane TNF in their neurons develop no apparent phenotypic abnormalities, suggesting that appropriate cellular interactions should form to allow for contact-dependent TNF signals to induce CNS pathology. These results demonstrate that target cells mediating the neuroinflammatory activities of TNF localize in the vicinity of astrocytes rather than neurons.
Similar articles
-
Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6.J Neurosci Res. 2003 Jul 15;73(2):176-87. doi: 10.1002/jnr.10635. J Neurosci Res. 2003. PMID: 12836160
-
Astrocyte-specific overexpression of insulin-like growth factor-I promotes brain overgrowth and glial fibrillary acidic protein expression.J Neurosci Res. 2004 Nov 15;78(4):472-84. doi: 10.1002/jnr.20288. J Neurosci Res. 2004. PMID: 15468174
-
Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic mice.Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):709-14. doi: 10.1073/pnas.0236046100. Epub 2003 Jan 9. Proc Natl Acad Sci U S A. 2003. PMID: 12522266 Free PMC article.
-
TNF-alpha transgenic and knockout models of CNS inflammation and degeneration.J Neuroimmunol. 1997 Feb;72(2):137-41. doi: 10.1016/s0165-5728(96)00184-1. J Neuroimmunol. 1997. PMID: 9042105 Review.
-
Transgenic models to assess the pathogenic actions of cytokines in the central nervous system.Mol Psychiatry. 1997 Mar;2(2):125-9. doi: 10.1038/sj.mp.4000225. Mol Psychiatry. 1997. PMID: 9106234 Review.
Cited by
-
Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease.Graefes Arch Clin Exp Ophthalmol. 2010 Nov;248(11):1531-51. doi: 10.1007/s00417-010-1485-8. Epub 2010 Aug 25. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 20737162 Review.
-
Quantitative Analysis of Cellular Proteome Alterations in CDV-Infected Mink Lung Epithelial Cells.Front Microbiol. 2017 Dec 22;8:2564. doi: 10.3389/fmicb.2017.02564. eCollection 2017. Front Microbiol. 2017. PMID: 29312244 Free PMC article.
-
Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period.J Virol. 2009 Sep;83(18):9356-69. doi: 10.1128/JVI.02382-07. Epub 2009 Jul 1. J Virol. 2009. PMID: 19570873 Free PMC article.
-
A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin alpha, or the p55TNF-R.J Exp Med. 1998 Oct 5;188(7):1343-52. doi: 10.1084/jem.188.7.1343. J Exp Med. 1998. PMID: 9763613 Free PMC article.
-
Candidate drug targets for prevention or modification of epilepsy.Annu Rev Pharmacol Toxicol. 2015;55:229-47. doi: 10.1146/annurev-pharmtox-010814-124607. Epub 2014 Aug 25. Annu Rev Pharmacol Toxicol. 2015. PMID: 25196047 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases